Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan S Johnston

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Microbial Cell Factories|September 5, 2022
Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffiiNeil C Dalvie, Christopher A Naranjo, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|March 17, 2023
Minimal purification method enables developability assessment of recombinant proteinsSergio A Rodriguez-Aponte, Christopher A Naranjo, Ryan S Johnston, et al.
Biotechnology and Bioengineering|November 15, 2024
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiYuchen Yang, Neil C Dalvie, Joseph R Brady, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Neil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|November 15, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiNeil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
Msphere|August 15, 2022
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC ChallengeTing Y Wong, Brynnan P Russ, Katherine S Lee, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Microbial Cell Factories|September 5, 2022
Steric accessibility of the N-terminus improves the titer and quality of recombinant proteins secreted from Komagataella phaffiiNeil C Dalvie, Christopher A Naranjo, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|March 17, 2023
Minimal purification method enables developability assessment of recombinant proteinsSergio A Rodriguez-Aponte, Christopher A Naranjo, Ryan S Johnston, et al.
Biotechnology and Bioengineering|November 15, 2024
Adaptation of Aglycosylated Monoclonal Antibodies for Improved Production in Komagataella phaffiiYuchen Yang, Neil C Dalvie, Joseph R Brady, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Neil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Biotechnology and Bioengineering|November 15, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiNeil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
Msphere|August 15, 2022
RBD-VLP Vaccines Adjuvanted with Alum or SWE Protect K18-hACE2 Mice against SARS-CoV-2 VOC ChallengeTing Y Wong, Brynnan P Russ, Katherine S Lee, et al.
Vaccine|January 7, 2023
Molecular engineering of a cryptic epitope in Spike RBD improves manufacturability and neutralizing breadth against SARS-CoV-2 variantsSergio A Rodriguez-Aponte, Neil C Dalvie, Ting Y Wong, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
Engineered SARS-CoV-2 receptor binding domain improves immunogenicity in mice and elicits protective immunity in hamstersNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2021
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in miceNeil C Dalvie, Sergio A Rodriguez-Aponte, Brittany L Hartwell, et al.
Pageof 1